Furthermore, the CTLA-4-deleted mice exhibited reduced susceptibility to MOG-induced experimental autoimmune encephalomyelitis (EAE) and did not exhibit an increased capacity to clear tumors, both opposite to expectations based on the concept that CTLA-4 inhibits autoimmunity and limits anti-tumor responses. This evidence concerns the gene CTLA4 and neoplasm.